Last reviewed: June 1, 2026

AMP-AD Knowledge Portal

Accelerating Medicines Partnership – Alzheimer's Disease (AMP-AD)

Data typeRNA-seq, proteomics, genomics, epigenomics

Specieshuman

Sample countThousands of brain tissue samples across multiple cohorts

Technologybulk RNA-seq, RRBS, proteomics, WGS, WES

Disease contextAlzheimer's disease, Brain aging

Notes

Major public resource for AD genomics and transcriptomics. Includes ROSMAP, Mount Sinai, Mayo Clinic RNA-seq cohorts. Requires registration for access.

Targets covered

TREM2 APOE BIN1 CD33 SPI1 INPP5D CSF1R PLCG2

Primary publication

Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal aids Alzheimer's drug discovery through open data sharing

Access dataset

Sources

AMP-AD Knowledge Portal · Link

Last reviewed: June 1, 2026